Left ventricular noncompaction is a rare structural cardiomyopathy that can occur isolated or in relationship with other conditions, mainly with musculoskeletal diseases or congenital heart defects. The association of left ventricular noncompaction and connective tissue disorders, including systemic lupus erythematosus, was scarcely described in the literature. Reported cases are, more likely, cardiomyopathies mimicking left ventricular noncompaction or transient left ventricular noncompaction with ventricular function improving after appropriate treatment.
INTRODUCTION
Left ventricular noncompaction (LVNC) is a rare structural abnormality of the left ventricular myocardium characterized by a spongy endocardial layer and a compacted epicardial layer [1] . The European Society of Cardiology Working Group on Myocardial and Pericardial Diseases categorized LVNC as either a familial unclassified cardiomyopathy or a morphological feature of many phenoltypically distinct cardiomyopathies [2] . Clinical heterogeneity ranges from asymptomatic to severe or life-threatening manifestations such as heart failure, ventricular arrhythmias or systemic thromboembolism [3] . The diagnosis is based on imaging: echocardiography and magnetic resonance (MRi). However, the existing diagnostic criteria have significant limitations which can result in overdiagnosis [4, 5] .
LVNC can occur either isolated, or associated with neuromuscular disorders or congenital heart defects [1] . Case reports describing the link between left ventricular noncompaction and systemic lupus erythematosus (SLE) conclude with the diagnosis of transient LVNC [6] or myocarditis [7] .
Herein, we report probably the first case of a patient with SLE and LVNC.
CLINICAL CASE
A 23-year-old Caucasian female presented to our Cardiology Department referred by her primary care physician for an abnormal electrocardiogram (ECG) and cardiomegaly on the chest x-ray. ECG ( Figure 1 ) showed poor R wave progression in leads V1-V3 and negative T waves in leads DI, DII, aVF, V4-V6. She was asymptomatic on admission. Personal and family medical history was negative for heart disease. Physical examination was normal, except for a grade III/VI systolic murmur heard over the apex, radiating to the axilla. Routine blood work was normal, except for an increased NT-proBNP of 3000 pg/mL (normal range 0-125 pg/mL).
Echocardiography ( Figure 2 ) showed left ventricular (LV) enlargement, severe systolic dysfunction with a LV ejection fraction of 25%, restrictive diastolic dysfunction and diffuse LV hypokinesia. LV apical and lateral wall trabeculations were detected, suggestive of left ventricular noncompaction (LVNC). Our patient met all the Stöllberger et al. refined echocardiographic diagnostic criteria (Table 1 ) [8] .
Cardiac MRi established the diagnosis, confirming LV trabecular mass more than 20% of the global LV mass and an increased ratio between the noncompacting and compacting myocardium > 2.3 in end-diastole ( Figure 3 ). Holter monitoring revealed multiple episodes of unsustained ventricular tachycardia.
Treatment with ramipril, bisoprolol, and spironolactone was initiated, as well as acenocumaroltitrated doses for a therapeutical INR. She received an implanted cardiac defibrillator for primary prevention of sudden cardiac death. After a few months, the patient was readmitted to the Internal Medicine Department for fever, weight loss and generalized lymph node enlargement. Clinical examination revealed livedo reticularis of the lower limbs, pale skin and mucosal membranes, non-scarring alopecia, generalized enlarged, mobile, painless lymph nodes, and hepatosplenomegaly. Cardiac auscultation was unchanged. Laboratory tests showed hemolytic anemia, lymphopenia, low complement levels, a high ANA titer, and positive anti-DNA and anti-Sm antibodies. She was diagnosed with systemic lupus erythematosus and received methylprednisolone pulse-therapy. Oral corticosteroid and hydroxychloroquine therapy was then started with significant clinical and biological improvement, except for the cardiac condition. ECG and echocardiographic aspects remained unchanged. Heart failure medication was revised and optimized, and the ICD was upgraded to resynchronization therapy with implanted cardiac defibrillator.
Five years later she was readmitted for decompensated heart failure. The echocardiogram showed persistent LV hypertrabeculation and worsened LV systolic dysfunction with a severely decreased LVEF of 15%. Clinical and biological decline occurred despite optimal medical and device therapy. The patient was then referred to a specialized heart transplant center.
DISCUSSION
Cardiac involvement is not uncommon in SLE. Pericarditis, myocarditis, nonbacterial endocarditis, coronary artery disease, premature coronary atherosclerosis or congestive heart failure are known to occur in SLE [9] . However, a cardiac manifestation in the form of a cardiomyopathy mimicking LVNC was rarely described in these patients [6, 7, 10] . In previously reported cases the proposed imaging criteria for LVNC were present, however the final diagnosis was cardiomyopathy resembling noncompaction [6, 7] or myocarditis with noncompaction features [10] . These reports also share a pattern of reversibility, with cardiac function improving after aggressive SLE treatment [6, 7, 10] . In the case we presented, all the Stöllberger and Finesterer [5] echocardiographic criteria were met, and LVNC diagnosis was confirmed by cardiac MRi. Our patient's systolic function had a continuous decline with no improvement after treating SLE. Furthermore, the initial diagnosis of LVNC was established before the patient presented the first SLE flair. In other cases, the aspect of LVNC was described as part of SLE activity or after initial SLE diagnosis [6, 7] . Considering all the available data, we consider LVNC as the most accurate diagnosis in our case, independent of SLE manifestations.
There is limited evidence regarding therapeutic efficacy in LVNC. Treatment involves three main objectives: heart failure therapy, antiarrhythmic therapy and antithrombotic therapy [11] . Our patient received the recommended heart failure treatment according to the European Society of Cardiology Heart Failure Guidelines [12] . Anticoagulation therapy is still a matter of debate in LVNC. In the case presented here anticoagulation was decided mainly because of the impaired systolic function. Oechslin and Jenni [13] indicated that prevention of embolic events should be considered if left ventricle ejection fraction is under 40%, since reduction of the blood flow can predispose to thrombus formation in the intertrabecular recesses. In some LVNC cases, the CHA 2 DS 2 -Vasc score can be a useful decision tool in establishing the indication of oral anticoagulation [14] . Primary prevention of sudden cardiac death is another critical issue in patients with LVNC. In our case an internal cardiac defibrillator was implanted after documenting a severely reduced LV ejection fraction. In LVNC patients implantation of a cardiac defibrillator should be considered following the guidelines for primary and secondary prevention of sudden cardiac death [1] .
In summary, we report one of the rare documented cases of SLE associated with "real" LVNC. Differentiating LVNC from other cardiomyopathies can be challenging, especially when it is part of a wider context such as a connective tissue disorder. The imaging diagnostic criteria are always useful, however the key to the diagnosis is to integrate each patient's characteristics into its unique clinical context.
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